Given recent findings that TGF-β inhibition prevents cardiac fibrosis development, along with our findings that STAT3 inhibition reduces TGF-β-dependent fibrosis development, a more complete understanding of TGF-β signaling in CCC would uncover additional signaling contributors to cardiac pathology. This evidence concerns the gene STAT3 and fibrosis.